Treatment of Huntington disease with -acetylenic GABA, an irreversible inhibitor of GABA- transaminase: Increased CSF GABA and homocarnosine without clinical amelioration (Q42244955)
Jump to navigation
Jump to search
scientific article published on February 1, 1981
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of Huntington disease with -acetylenic GABA, an irreversible inhibitor of GABA- transaminase: Increased CSF GABA and homocarnosine without clinical amelioration |
scientific article published on February 1, 1981 |
Statements
1 reference
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration (English)
1 reference
Treatment of Huntington disease with -acetylenic GABA, an irreversible inhibitor of GABA- transaminase: Increased CSF GABA and homocarnosine without clinical amelioration (English)
1 reference
Agid Y
1 reference
G. Tell
P. Böhlen
P. J. Schechter
J. Koch-Weser
A. M. Bonnet
G. Coquillat
G. Chazot
1 February 1981
1 reference
1 reference
31
1 reference
2
1 reference
207-211
1 reference
Identifiers
1 reference
1 reference